JP2007513976A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007513976A5 JP2007513976A5 JP2006544134A JP2006544134A JP2007513976A5 JP 2007513976 A5 JP2007513976 A5 JP 2007513976A5 JP 2006544134 A JP2006544134 A JP 2006544134A JP 2006544134 A JP2006544134 A JP 2006544134A JP 2007513976 A5 JP2007513976 A5 JP 2007513976A5
- Authority
- JP
- Japan
- Prior art keywords
- chain constant
- constant domain
- heavy chain
- light chain
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60894403P | 2003-12-15 | 2003-12-15 | |
| PCT/US2004/042312 WO2005058251A2 (en) | 2003-12-15 | 2004-12-15 | Hla-dr-specific antibodies, compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007513976A JP2007513976A (ja) | 2007-05-31 |
| JP2007513976A5 true JP2007513976A5 (cg-RX-API-DMAC7.html) | 2007-12-27 |
Family
ID=34700255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006544134A Pending JP2007513976A (ja) | 2003-12-15 | 2004-12-15 | Ｈｌａ−ｄｒ特異的抗体、組成物、および方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8354507B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1711527A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007513976A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2550155C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005058251A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007042809A2 (en) * | 2005-10-11 | 2007-04-19 | Domantis Limited | Antibody polypeptide library screening and selected antibody polypeptides |
| GB0525214D0 (en) * | 2005-12-12 | 2006-01-18 | Bioinvent Int Ab | Biological materials and uses thereof |
| US9085614B2 (en) * | 2008-08-01 | 2015-07-21 | Immunas Pharma, Inc. | Antibodies that specifically bind to Aβ oligomers and uses thereof |
| CA3220104A1 (en) * | 2010-06-08 | 2011-12-15 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
| CN104203982B (zh) | 2011-10-28 | 2018-08-31 | 特瓦制药澳大利亚私人有限公司 | 多肽构建体及其用途 |
| JP2016530244A (ja) * | 2013-12-31 | 2016-09-29 | ディベロップメント センター フォー バイオテクノロジーＤｅｖｅｌｏｐｍｅｎｔ Ｃｅｎｔｅｒ Ｆｏｒ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ | 抗ｖｅｇｆ抗体及びその使用 |
| CA2987992A1 (en) * | 2015-06-04 | 2016-12-08 | University Of Southern California | Lym-1 and lym-2 targeted car cell immunotherapy |
| KR20180087430A (ko) * | 2015-12-17 | 2018-08-01 | 얀센 바이오테크 인코포레이티드 | Hla-dr에 특이적으로 결합하는 항체 및 이의 용도 |
| EP3515491A4 (en) | 2016-09-21 | 2020-09-16 | Aptevo Research and Development LLC | CD123 BINDING PROTEINS AND RELATED COMPOSITIONS AND PROCESSES |
| EP3515493A4 (en) * | 2016-09-23 | 2020-08-19 | University of Southern California | CHEMERICAL ANTIGEN RECEPTORS, COORESPONDENT COMPOSITIONS AND METHODS OF USE |
| JP7280238B2 (ja) * | 2017-07-17 | 2023-05-23 | ヤンセン バイオテツク，インコーポレーテツド | フィブロネクチンｉｉｉ型ドメインに対する抗原結合領域及びその使用方法 |
| SG11202108655TA (en) | 2019-02-15 | 2021-09-29 | Univ Southern California | Lym-1 and lym-2 antibody compositions and improved car constructs |
| CN113950483B (zh) * | 2019-04-01 | 2025-08-05 | 中外制药株式会社 | 抗hla-dq2.5抗体 |
| CN115028730B (zh) * | 2022-05-17 | 2022-11-08 | 诺赛联合(北京)生物医学科技有限公司 | 一种成体干细胞衍生的类器官制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO873164L (no) | 1986-07-30 | 1988-02-01 | Teijin Ltd | Muse-humane kimaere antistoffer. |
| JPH0698021B2 (ja) | 1986-08-01 | 1994-12-07 | 帝人株式会社 | マウス−ヒトキメラ抗体、それをコ−ドする発現型キメラｄｎａ配列、プラスミド及び細胞 |
| US6180377B1 (en) | 1993-06-16 | 2001-01-30 | Celltech Therapeutics Limited | Humanized antibodies |
| PT877626E (pt) | 1996-01-23 | 2003-01-31 | Univ Vermont And State Agric C | Anticorpos anti-cd1s para utilizacao contra icto |
| KR100764256B1 (ko) * | 1998-01-23 | 2007-10-05 | 에프. 호프만-라 로슈 아게 | 인간 인터루킨-12에 대한 항체 |
| AU5588099A (en) * | 1998-08-28 | 2000-03-21 | Dendreon Corporation | Selective apoptosis of neoplastic cells by an hla-dr specific monoclonal antibody |
| CN1360596A (zh) * | 1999-02-12 | 2002-07-24 | 遗传研究所有限公司 | 与b7分子发生反应的人源化免疫球蛋白及应用该免疫球蛋白的治疗方法 |
| ATE365749T1 (de) | 2000-05-12 | 2007-07-15 | Gpc Biotech Ag | Humane peptide/proteine, die das töten von zellen,einschliesslich lymphoide tumorzellen, herbeiführen oder bewirken |
| EP1369431A4 (en) * | 2001-10-15 | 2005-01-12 | Kirin Brewery | ANTI-HLA-DR ANTIBODIES |
| JP4723810B2 (ja) * | 2001-12-03 | 2011-07-13 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | ハイブリッド抗体 |
| US8450348B2 (en) * | 2007-02-21 | 2013-05-28 | Forma Tm, Llc | Derivatives of squaric acid with anti-proliferative activity |
-
2004
- 2004-12-15 EP EP04814490A patent/EP1711527A4/en not_active Ceased
- 2004-12-15 JP JP2006544134A patent/JP2007513976A/ja active Pending
- 2004-12-15 WO PCT/US2004/042312 patent/WO2005058251A2/en not_active Ceased
- 2004-12-15 US US11/013,537 patent/US8354507B2/en not_active Expired - Fee Related
- 2004-12-15 CA CA2550155A patent/CA2550155C/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2649155T3 (es) | Anticuerpos anti-OX40 y procedimientos de uso de los mismos | |
| JP7433656B2 (ja) | 第３シグナル受容体を含むキメラ抗原受容体およびその使用 | |
| DE60333732D1 (de) | Internalisierung von anti cd74 monoklonalen antikörpern und deren verwendungen | |
| ME02300B (me) | Anti cd37 antitijela | |
| JP2014503189A5 (cg-RX-API-DMAC7.html) | ||
| JP2010533498A5 (cg-RX-API-DMAC7.html) | ||
| WO2004029092A8 (fr) | Anticorps pour adcc et induisant la production de cytokines. | |
| RU2006144820A (ru) | Антитела, связывающиеся с рецепторами kir2dl1,-2,-3 и не связывающиеся с рецептором kir2ds4, и их терапевтическое применение | |
| DE69721713D1 (de) | Humaner monoklonaler antikörper gegen hepatitis b virus oberflächen antigen (hbvsag) | |
| RU2017136072A (ru) | Триспецифические связывающие молекулы для лечения вирусной инфекции гепатита в и связанных состояний | |
| DE60116753D1 (de) | Humanisierte antikörper gegen den epidermalen wachstumsfaktorrezeptor | |
| JP2014509187A5 (cg-RX-API-DMAC7.html) | ||
| JP2010526028A5 (cg-RX-API-DMAC7.html) | ||
| JP2019522490A5 (cg-RX-API-DMAC7.html) | ||
| JP2004248677A5 (cg-RX-API-DMAC7.html) | ||
| JP2009502171A5 (cg-RX-API-DMAC7.html) | ||
| JP2013529084A5 (cg-RX-API-DMAC7.html) | ||
| JP2010535012A5 (cg-RX-API-DMAC7.html) | ||
| MX2011012047A (es) | Inmunoglobulinas humanas anti-cd52. | |
| JP2014509837A5 (cg-RX-API-DMAC7.html) | ||
| JP2015514110A5 (cg-RX-API-DMAC7.html) | ||
| RU2571204C3 (ru) | Специфические связывающие агенты против в7-н1 | |
| WO2010055366A3 (en) | Anti-human il-21 monoclonal antibodies | |
| JP2022515152A5 (cg-RX-API-DMAC7.html) | ||
| JP2014530001A5 (cg-RX-API-DMAC7.html) |